Nigella sativa L. (Black Cumin): A Promising Natural Remedy for Wide Range of Illnesses

EM Yimer, KB Tuem, A Karim… - Evidence‐Based …, 2019 - Wiley Online Library
The seed of Nigella sativa (N. sativa) has been used in different civilization around the world
for centuries to treat various animal and human ailments. So far, numerous studies …

Autophagy and autophagy signaling in Epilepsy: Possible role of autophagy activator

NH Ali, HM Al-Kuraishy, AI Al-Gareeb, SA Alnaaim… - Molecular …, 2023 - Springer
Autophagy is an explicit cellular process to deliver dissimilar cytoplasmic misfolded proteins,
lipids and damaged organelles to the lysosomes for degradation and elimination. The …

Potential effect of hydroxychloroquine in diabetes mellitus: a systematic review on preclinical and clinical trial studies

DZ Wondafrash, TZ Desalegn, EM Yimer… - Journal of diabetes …, 2020 - Wiley Online Library
Background. Diabetes mellitus is a chronic metabolic disorder characterized by persistent
hyperglycemia. It affects millions of people globally. In spite of many antidiabetic drugs that …

Metformin: activation of 5′ AMP-activated protein kinase and its emerging potential beyond anti-hyperglycemic action

S Goel, R Singh, V Singh, H Singh, P Kumari… - Frontiers in …, 2022 - frontiersin.org
Metformin is a plant-based drug belonging to the class of biguanides and is known to treat
type-2 diabetes mellitus (T2DM). The drug, combined with controlling blood glucose levels …

New insights on the potential anti‐epileptic effect of metformin: Mechanistic pathway

SA Alnaaim, HM Al‐kuraishy… - Journal of Cellular …, 2023 - Wiley Online Library
Epilepsy is a chronic neurological disease characterized by recurrent seizures. Epilepsy is
observed as a well‐controlled disease by anti‐epileptic agents (AEAs) in about 69 …

Neuroinflammation and Epilepsy: From Pathophysiology to Therapies Based on Repurposing Drugs

P Sanz, T Rubio, MA Garcia-Gimeno - International Journal of Molecular …, 2024 - mdpi.com
Neuroinflammation and epilepsy are different pathologies, but, in some cases, they are so
closely related that the activation of one of the pathologies leads to the development of the …

Repurposing of the β-lactam antibiotic, ceftriaxone for neurological disorders: a review

EM Yimer, HZ Hishe, KB Tuem - Frontiers in Neuroscience, 2019 - frontiersin.org
To date, there is no cure or disease-modifying agents available for most well-known
neurological disorders. Current therapy is typically focused on relieving symptoms and …

[HTML][HTML] A review on role of metformin as a potential drug for epilepsy treatment and modulation of epileptogenesis

R Singh, SC Sarangi, S Singh, M Tripathi - Seizure, 2022 - Elsevier
Background Available anti-seizure medications (ASMs) target the symptomatology of the
disease rather than any significant disease/epileptogenesis modifying actions. There are …

Beneficial effects of metformin on the central nervous system, with a focus on epilepsy and Lafora disease

P Sanz, JM Serratosa, MP Sánchez - International Journal of Molecular …, 2021 - mdpi.com
Metformin is a drug in the family of biguanide compounds that is widely used in the treatment
of type 2 diabetes (T2D). Interestingly, the therapeutic potential of metformin expands its …

Metformin: The Winding Path from Understanding Its Molecular Mechanisms to Proving Therapeutic Benefits in Neurodegenerative Disorders

LM Isop, AE Neculau, RD Necula, C Kakucs, MA Moga… - Pharmaceuticals, 2023 - mdpi.com
Metformin, a widely prescribed medication for type 2 diabetes, has garnered increasing
attention for its potential neuroprotective properties due to the growing demand for …